Bottom line
MNTL vs PRHSX: the short answer
MNTL (Tema Neuroscience and Mental Health ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs.
Updated Nov 19, 2026
MNTL vs PRHSX side by side
| MNTL | PRHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Innovator | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | — | 0.83% |
| Annual cost per $10k | — | $83 |
| 10-yr cost on $10k (prospectus) | — | $1,025 |
| Max front load | None | — |
| 12b-1 fee | — | — |
| 1-yr return | — | +17.7% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | +9.1% |
| Best quarter | — | +23.5% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | — | $11.9B |
| Number of holdings | — | 279 |
| Portfolio turnover | — | 62% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MNTL and PRHSX share none of their top holdings.
MNTL top 10
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between MNTL and PRHSX?
MNTL (Tema Neuroscience and Mental Health ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs.
Should I own both MNTL and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.